XV Congreso Nacional de Neuropsicolgía FANPSE 2024
PDF Document
Chemostart VII Edition
ChemoStart is a global program of Insud Pharma that helps boost startups and companies with innovative projects in health and healthcare.
Alicante companies receive the keys to adapt to the high speed imposed by technology
Pablo Belmonte, Newmanbrain CEO, shares a discussion table in the edition of “SOFTING TIC&TALK” of ITI that is held in Alicante.
El capital riesgo busca en Alicante el próximo unicornio: ‘startups’ y fondos se citan en Alia
Startups como Newmanbrain han demostrando que su idea y su modelo de negocio eran viables, dando además un ‘pelotazo’ como empresas de base tecnológica.
Identifying ADHD boys by very-low frequency prefrontal fNIRS fluctuations during a rhythmic mental arithmetic task
Early detection of MCI and fNIRs technology
MCI or Mild Cognitive Impairment, is a condition in which patients experiment a cognitive decline that is greater than what is expected for their age and education level. Having MCI does not necessary lead to dementia. However, individuals that present MCI, are more likely to develop a dementia than those who do not present this […]
THEIA™ Wins Prestigious Design Award
We are thrilled to announce that our latest fNIRs device, THEIA™, has been awarded an iF Design Award 2023.
Newmanbrain, elegida entre las 100 start-ups referentes del sector Salud en el mundo por su sistema de diagnóstico cerebral con IA
La firma ha sido escogida entre las 250 empresas de base tecnológica que presentaron su candidatura a la convocatoria de este evento celebrado en Madrid.
Newmanbrain among the 100 startups in healthcare
Last week, Newmanbrain participated in the 100 Startups Health event at La Nave in Madrid. More than 250 companies worldwide submitted their applications to take part in the event, and Newmanbrain was among the 100 selected ones. Our CEO, Pablo Belmonte, and our Project Manager, Irene Tortosa, attended the event on behalf of Newmanbrain. They […]
Newmanbrain, pionera en el desarrollo de un sistema de diagnóstico cerebral con Inteligencia Artificial
La innovación de Newmanbrain facilita al profesional sanitario la detección de trastornos neurológicos y mentales como el deterioro cognitivo del envejecimiento o el TDAH en niños.